These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34602806)

  • 21. Fostemsavir: A Novel Attachment Inhibitor for Patients With Multidrug-Resistant HIV-1 Infection.
    Hiryak K; Koren DE
    Ann Pharmacother; 2021 Jun; 55(6):792-797. PubMed ID: 32964736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A survey of core replacements in indole-based HIV-1 attachment inhibitors.
    Wang T; Wallace OB; Zhang Z; Fang H; Yang Z; Robinson BA; Spicer TP; Gong YF; Blair WS; Shi PY; Lin PF; Deshpande M; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1423-1429. PubMed ID: 30940396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of virological response and assessment of resistance emergence to the HIV-1 attachment inhibitor BMS-626529 during 8-day monotherapy with its prodrug BMS-663068.
    Ray N; Hwang C; Healy MD; Whitcomb J; Lataillade M; Wind-Rotolo M; Krystal M; Hanna GJ
    J Acquir Immune Defic Syndr; 2013 Sep; 64(1):7-15. PubMed ID: 23614999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068.
    Nowicka-Sans B; Gong YF; McAuliffe B; Dicker I; Ho HT; Zhou N; Eggers B; Lin PF; Ray N; Wind-Rotolo M; Zhu L; Majumdar A; Stock D; Lataillade M; Hanna GJ; Matiskella JD; Ueda Y; Wang T; Kadow JF; Meanwell NA; Krystal M
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3498-507. PubMed ID: 22547625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fostemsavir: a new CD4 attachment inhibitor.
    Cahn P; Fink V; Patterson P
    Curr Opin HIV AIDS; 2018 Jul; 13(4):341-345. PubMed ID: 29771694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir.
    Bouba Y; Berno G; Fabeni L; Carioti L; Salpini R; Aquaro S; Svicher V; Perno CF; Ceccherini-Silberstein F; Santoro MM
    J Antimicrob Chemother; 2020 Jul; 75(7):1778-1786. PubMed ID: 32160290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gp120 substitutions at positions associated with resistance to fostemsavir in treatment-naive HIV-1-positive individuals.
    Lepore L; Fabrizio C; Bavaro DF; Milano E; Volpe A; Lagioia A; Angarano G; Saracino A; Monno L
    J Antimicrob Chemother; 2020 Jun; 75(6):1580-1587. PubMed ID: 32191306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of HIV-1 attachment. Part 9: an assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative.
    Yeung KS; Qiu Z; Yang Z; Zadjura L; D'Arienzo CJ; Browning MR; Hansel S; Huang XS; Eggers BJ; Riccardi K; Lin PF; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2013 Jan; 23(1):209-12. PubMed ID: 23200244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.
    Lai YT; Wang T; O'Dell S; Louder MK; Schön A; Cheung CSF; Chuang GY; Druz A; Lin B; McKee K; Peng D; Yang Y; Zhang B; Herschhorn A; Sodroski J; Bailer RT; Doria-Rose NA; Mascola JR; Langley DR; Kwong PD
    Nat Commun; 2019 Jan; 10(1):47. PubMed ID: 30604750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Implementation Science: Linking Fundamental Discovery Science and Innovation Science to Ending the HIV Epidemic at the Community Level.
    Eisinger RW; Dieffenbach CW; Fauci AS
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S171-S172. PubMed ID: 31764250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors.
    Kazmierski WM; Xia B; Miller J; De la Rosa M; Favre D; Dunham RM; Washio Y; Zhu Z; Wang F; Mebrahtu M; Deng H; Basilla J; Wang L; Evindar G; Fan L; Olszewski A; Prabhu N; Davie C; Messer JA; Samano V
    J Med Chem; 2020 Apr; 63(7):3552-3562. PubMed ID: 32073266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
    Wang L; Sarafianos SG; Wang Z
    Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 13. Synthesis and profiling of a novel amminium prodrug of the HIV-1 attachment inhibitor BMS-585248.
    Regueiro-Ren A; Simmermacher-Mayer J; Sinz M; Johnson KA; Huang XS; Jenkins S; Parker D; Rahematpura S; Zheng M; Meanwell NA; Kadow JF
    J Med Chem; 2013 Feb; 56(4):1670-6. PubMed ID: 23374053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors.
    Raheem IT; Walji AM; Klein D; Sanders JM; Powell DA; Abeywickrema P; Barbe G; Bennet A; Childers K; Christensen M; Clas SD; Dubost D; Embrey M; Grobler J; Hafey MJ; Hartingh TJ; Hazuda DJ; Kuethe JT; McCabe Dunn J; Miller MD; Moore KP; Nolting A; Pajkovic N; Patel S; Peng Z; Rada V; Rearden P; Schreier JD; Sisko J; Steele TG; Truchon JF; Wai J; Xu M; Coleman PJ
    J Med Chem; 2015 Oct; 58(20):8154-65. PubMed ID: 26397965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.
    Hartman TL; Yang L; Helfrick AN; Hassink M; Shank NI; George Rosenker K; Scerba MT; Saha M; Hughes E; Wang AQ; Xu X; Gupta P; Buckheit RW; Appella DH
    Antiviral Res; 2016 Oct; 134():216-225. PubMed ID: 27568924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a Potent HIV Integrase Inhibitor that Leads to a Prodrug with Significant anti-HIV Activity.
    Seo BI; Uchil VR; Okello M; Mishra S; Ma XH; Nishonov M; Shu Q; Chi G; Nair V
    ACS Med Chem Lett; 2011 Oct; 2(12):877-881. PubMed ID: 22328963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
    Krise JP; Charman WN; Charman SA; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fostemsavir Tromethamine.
    Am J Health Syst Pharm; 2020 Nov; 77(23):1924-1927. PubMed ID: 32936234
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.